AN IMMUNOGLOBULIN-LIKE DOMAIN DETERMINES THE SPECIFICITY OF NEUROTROPHIN RECEPTORS

被引:126
作者
URFER, R
TSOULFAS, P
OCONNELL, L
SHELTON, DL
PARADA, LF
PRESTA, LG
机构
[1] GENENTECH INC, DEPT NEUROSCI, San Francisco, CA 94080 USA
[2] NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MOLEC EMBRYOL SECT, FREDERICK, MD 21702 USA
关键词
BINDING DOMAIN; NEUROTROPHINS; TRK; TYROSINE KINASE RECEPTOR;
D O I
10.1002/j.1460-2075.1995.tb07279.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neurotrophins influence survival and maintenance of vertebrate neurons in the embryonic, early postnatal and post-developmental stages of the nervous system. Binding of neurotrophins to receptors encoded by the gene family trk initiates signal transduction into the cell, trkA interacts preferably with nerve growth factor (NGF), trkB with brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5) and trkC with neurotrophin-3 (NT-3), By constructing 17 different chimeras and domain deletions of the human trk receptors and analyzing their binding affinities to the neurotrophins we have shown that an immunoglobulin-like domain located adjacent to the transmembrane domain is the structural element that determines the interaction of neurotrophins with their receptors. Chimeras of trkC where this domain was exchanged for the homologous sequences from trkB or trkA gained high affinity binding to BDNF or NGF respectively, while deletion of this domain in trkC or trkA abolished binding to NT-3 or NGF respectively, This domain alone retained affinities to neurotrophins similar to the full-length receptors and when expressed on NIH 3T3 cells in fusion with the kinase domain showed neurotrophin-dependent activation.
引用
收藏
页码:2795 / 2805
页数:11
相关论文
共 43 条
  • [1] Ashkenazi A, 1993, Int Rev Immunol, V10, P219, DOI 10.3109/08830189309061697
  • [2] BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B
  • [3] NEUROTROPHIN RECEPTORS - A WINDOW INTO NEURONAL DIFFERENTIATION
    CHAO, MV
    [J]. NEURON, 1992, 9 (04) : 583 - 593
  • [4] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [5] HUMAN TRK ONCOGENES ACTIVATED BY POINT MUTATION, IN-FRAME DELETION, AND DUPLICATION OF THE TYROSINE KINASE DOMAIN
    COULIER, F
    KUMAR, R
    ERNST, M
    KLEIN, R
    MARTINZANCA, D
    BARBACID, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (08) : 4202 - 4210
  • [6] DAVIES AM, 1993, J NEUROSCI, V13, P4961
  • [7] THE NEUROTROPHINS BDNF, NT-3, AND NGF DISPLAY DISTINCT PATTERNS OF RETROGRADE AXONAL-TRANSPORT IN PERIPHERAL AND CENTRAL NEURONS
    DISTEFANO, PS
    FRIEDMAN, B
    RADZIEJEWSKI, C
    ALEXANDER, C
    BOLAND, P
    SCHICK, CM
    LINDSAY, RM
    WIEGAND, SJ
    [J]. NEURON, 1992, 8 (05) : 983 - 993
  • [8] A SOLUBLE CHIMERIC FORM OF THE L1 GLYCOPROTEIN STIMULATES NEURITE OUTGROWTH
    DOHERTY, P
    WILLIAMS, E
    WALSH, FS
    [J]. NEURON, 1995, 14 (01) : 57 - 66
  • [9] CHARACTERIZATION OF NEUROTROPHIN RECEPTORS BY AFFINITY CROSS-LINKING
    ESCANDON, E
    BURTON, LE
    SZONYI, E
    NIKOLICS, K
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (06) : 601 - 613
  • [10] ESCANDON E, 1994, J NEUROSCI, V14, P2054